Abstract:Abstract BACKGROUND Inflammatory Bowel Disease (IBD), encompassing conditions such as Crohn's disease and ulcerative colitis, has been a growing concern globally. While its burden has been studied extensively, the specific impact on women, who face unique physiological and socio-cultural challenges, remains underexplored. Grasping the global, national, and regional implications of IBD in women across 204 countries and territories provides a comprehensive understanding to guide healthcare strategies and tailor patient management. METHOD Using data from the Global Burden of Disease tool, we estimated the prevalence, incidence, mortality, and Disability Adjusted Life Years (DALYs) associated with IBD in women by age, year, and location from 1990 to 2019 across 204 countries and territories. Non-fatal health parameters, such as incidence and prevalence, were calculated using the DisMod-MR 2.1 tool. Fatal health outcomes were discerned using the Cause of Death Ensemble Model (CODEm) framework. This comprehensive approach allowed for a detailed, standardized, and comparative analysis of the IBD burden on women at global, national, and regional levels, considering the variations by age and over time. RESULTS From 1990 to 2019, there was a notable rise in the annual percentage change (APC) of IBD metrics in women, with prevalence increasing by 43% (95%UI: 39-47), deaths by 73% (48-116), DALYs by 27% (11-55), and incidence by 36% (31-40). However, when examining age-standardized rates, there was a decrease in incidence by 20%, death rates by 18%, and DALYs by 27% over the same period. Regionally, Southeast Asia, East Asia, and Oceania saw the sharpest surge in incidence rates at 104%, trailed by the Middle socio-demographic index at 37% and North Africa and the Middle East at 26%. Mortality rates were most pronounced in the European Union with a 37% APC increase, followed by high-income countries at 22% and OECD countries at 20%. DALYs rates revealed the European Union leading with a 13% APC growth, while the Nordic Region saw a 4% increase. When dissected by age groups, those under 20 years exhibited the most significant rise in incidence rates at 7% per 100,000, closely followed by children under 5 at 5%. CONCLUSIONS The rising burden of IBD in women from 1990 to 2019, particularly in regions like Southeast Asia, East Asia, Oceania, and the European Union, underscores the pressing need for targeted healthcare strategies and interventions. The distinct variations observed across age groups, especially among the younger population, further highlight the importance of early detection and intervention. Given the significant socio-economic and health implications, it's imperative to prioritize women-centric IBD research and clinical care, ensuring that healthcare policies and practices are tailored to address these specific challenges. Age-standardized Mortality rate (per 100,000 person years), Female, due to IBD in Global Burden of Disease Super region, from 1990-2019. Age-wise distribution of incidence (per 100,000) Inflammatory Bowel Disease, Global, Female.

Inflammatory Bowel Disease In Youth Under 20 From 1990-2019: A Global Perspective On Regional And National Variations From The Gbd 2019 Analysis

Global Burden of Inflammatory Bowel Disease Among Children and Adolescents: A Comprehensive Analysis (1990-2019)

Geographical and sociodemographic epidemiology of inflammatory bowel disease in young females from 2010 to 2019

Epidemiological analysis reveals a surge in inflammatory bowel disease among children and adolescents: A global, regional, and national perspective from 1990 to 2019 - insights from the China study

EVOLVING LANDSCAPE OF INFLAMMATORY BOWEL DISEASE IN G20 NATIONS (1990-2019): A COMPREHENSIVE GLOBAL ASSESSMENT

The global, regional, and national burden of inflammatory bowel diseases, 1990-2019: A systematic analysis for the global burden of disease study 2019

Unraveling the global burden of inflammatory bowel disease (1990-2019): A Joinpoint regression analysis of divergent trends in 10-24 and 50-69 age cohorts

Trends of inflammatory bowel disease from the Global Burden of Disease Study (1990-2019)

Inflammatory bowel disease: estimates from the global burden of disease 2017 study

TRENDS OF INFLAMMATORY BOWEL DISEASE BURDEN IN THE UNITED STATES (1990-2019), PROJECTIONS OF DEATHS TO 2040: INSIGHTS FROM THE 2019 GLOBAL BURDEN OF DISEASE STUDY

Rapid rise in incidence of Irish paediatric inflammatory bowel disease

The national burden of inflammatory bowel disease in the United States from 1990-2019: results from the Global Burden of Disease study database

The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

EVOLVING BURDEN OF INFLAMMATORY BOWEL DISEASE IN WOMEN FROM 1990-2019: GLOBAL, REGIONAL, NATIONAL VARIATIONS, AGE DYNAMICS, AND IMPLICATIONS FOR GLOBAL HEALTH

Analysis of global prevalence, DALY and trends of inflammatory bowel disease and their correlations with sociodemographic index: Data from 1990 to 2019

Global Epidemiology and Geographic Variations of Pediatric-Onset Inflammatory Bowel Disease: A Comprehensive Analysis of the Global Burden of Disease Study 1990 to 2019

Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review

Global, regional, and national burden of inflammatory bowel disease, 1990-2021: Insights from the global burden of disease 2021

Disease Burden of Inflammatory Bowel Disease in China from 1990 to 2019 and Its Predictions

SHIFTS IN IBD INCIDENCE, MORTALITY, AND BURDEN: A COMPREHENSIVE ANALYSIS OF US AND GLOBAL TRENDS (1990-2019)

Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019